ENXTBR:ARGX
ENXTBR:ARGXBiotechs

How FDA Priority Review of VYVGART for Seronegative gMG At argenx (ENXTBR:ARGX) Has Changed Its Investment Story

argenx SE recently announced that the U.S. FDA has accepted for priority review a supplemental Biologics License Application for VYVGART to treat adults with acetylcholine receptor antibody seronegative generalized myasthenia gravis, supported by the Phase 3 ADAPT SERON study that met its primary endpoint. This filing, which covers all three seronegative gMG subtypes (MuSK+, LRP4+, and triple seronegative), highlights an effort to expand treatment options for a group of patients with fewer...
ENXTBR:DEME
ENXTBR:DEMEConstruction

Assessing DEME Group (ENXTBR:DEME) Valuation After New Offshore Wind Vessel Norse Energi Expands Installation Capacity

Offshore wind vessel delivery and what it might mean for DEME Group shares DEME Group (ENXTBR:DEME) has taken delivery of Norse Energi, its second new wind turbine installation vessel, expanding its ability to handle next generation offshore wind projects and putting fresh attention on the stock. See our latest analysis for DEME Group. The delivery of Norse Energi comes at a time when DEME Group’s share price has a 30 day share price return of 11.46% and a 90 day share price return of 14.92%,...
ENXTBR:EXM
ENXTBR:EXMOil and Gas

European Dividend Stocks To Enhance Your Portfolio

As the European markets show resilience with the STOXX Europe 600 Index rising by 0.77% amid strong economic data and mixed earnings results, investors are increasingly looking for stability in their portfolios. In this environment, dividend stocks can offer a reliable income stream and potential for capital appreciation, making them an attractive option for those seeking to enhance their investment strategies.
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Assessing Solvay (ENXTBR:SOLB) Valuation After Recent Share Price Weakness

What recent performance says about Solvay Solvay (ENXTBR:SOLB) has drawn investor attention after a mixed run in its share price, with a 1.7% gain over the past day contrasting with weaker returns over the past month and past 3 months. That short term rebound comes after a 6.5% decline over the past month and a 10.3% drop over the past 3 months, while the 1 year total return is down 10.6% and the year to date performance shows a 7.8% decline. See our latest analysis for Solvay. The €25.22...
ENXTBR:AGS
ENXTBR:AGSInsurance

Ageas (ENXTBR:AGS) Valuation After Raised 2025 Guidance From Taiping Life Tax Update

Why the latest update on ageas (ENXTBR:AGS) matters Ageas (ENXTBR:AGS) raised its 2025 Net Operating Result guidance to a range of €1.6b to €1.65b, after new corporate income tax treatments under IFRS17/9 benefited its Chinese joint venture Taiping Life. See our latest analysis for ageas. The guidance upgrade arrives after a period where momentum has been relatively steady, with a 90 day share price return of 4.55% and a 1 year total shareholder return of 27.91% building on multi year...
ENXTBR:ABI
ENXTBR:ABIBeverage

What Anheuser-Busch InBev (ENXTBR:ABI)'s Exclusive Live Nation UK Partnership Means For Shareholders

In January 2026, Live Nation announced AB InBev as the exclusive beer and cider partner across major UK festivals, venues, and outdoor shows, putting brands like Budweiser, Corona, San Miguel and Stella Artois at the centre of the live music scene for fans of legal drinking age. The partnership deepens a long-running global relationship between the brewer and the live entertainment group, giving AB InBev extensive on-the-ground and digital exposure at more than 20 festivals and Academy Music...
ENXTBR:AGS
ENXTBR:AGSInsurance

European Dividend Stocks To Enhance Your Portfolio

As the European markets show resilience with the STOXX Europe 600 Index ending higher, supported by robust economic data and earnings results, investors are increasingly considering dividend stocks to enhance their portfolios. In this context, selecting stocks with a strong track record of consistent dividend payouts can be an effective strategy for those looking to balance growth and income in today's dynamic market environment.
ENXTBR:KBC
ENXTBR:KBCBanks

European Dividend Stocks To Consider For Your Portfolio

As the European markets experience a mix of resilience and fluctuation, with the STOXX Europe 600 Index showing gains supported by solid economic data, investors are increasingly looking at dividend stocks as a potential source of stable income. In light of these market dynamics, selecting dividend stocks that offer consistent payouts and align well with current economic conditions can be an effective strategy for building a robust portfolio.
ENXTBR:UMI
ENXTBR:UMIChemicals

Is Umicore (ENXTBR:UMI) Pricing Look Stretched After Its Sharp One Year Rebound

If you are wondering whether Umicore is priced attractively right now, it helps to step back and look at what the recent share performance and current valuation are really telling you. The share price is at €19.04, with a 2.0% decline over the last 7 days, a 9.1% gain over 30 days, a 2.4% gain year to date, an 88.6% gain over 1 year, and declines of 39.7% and 55.7% over 3 and 5 years respectively, which together provide mixed signals about growth potential and risk. Recent coverage around...
ENXTBR:DIE
ENXTBR:DIERetail Distributors

Is Berenberg’s Focus On Belron Reframing D'Ieteren Group’s (ENXTBR:DIE) Long-Term Value Story?

Berenberg recently initiated research coverage on D'Ieteren Group, assigning a positive view and emphasizing the company’s concentrated portfolio and core holding in Belron. The broker’s focus on structural growth, resilient cash generation, and the impact of D'Ieteren’s 2024 shareholder reorganization brings fresh attention to the group’s long-term value creation profile. We’ll now examine how Berenberg’s emphasis on Belron as the key value driver shapes D'Ieteren Group’s broader investment...
ENXTBR:DECB
ENXTBR:DECBBuilding

European Penny Stocks To Watch In January 2026

The European market has shown resilience, with major stock indexes like the STOXX Europe 600 Index climbing higher amid optimism about the economy and company earnings. For investors interested in smaller or newer companies, penny stocks—though an antiquated term—remain a viable investment area due to their affordability and potential for growth. When these stocks are supported by solid financial health, they can offer surprising value and stability, making them worth watching closely.